comparemela.com

Page 2 - Quarter For Supernus Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Insider Selling: Supernus Pharmaceuticals, Inc (NASDAQ:SUPN) VP Sells 14,491 Shares of Stock

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Get Free Report) VP Padmanabh P. Bhatt sold 14,491 shares of the firm’s stock in a transaction that occurred on Thursday, March 21st. The shares were sold at an average price of $35.31, for a total transaction of $511,677.21. Following the transaction, the vice president now directly owns 8,570 shares […]

Lazard Asset Management LLC Has $327,000 Stock Position in Supernus Pharmaceuticals, Inc (NASDAQ:SUPN)

Lazard Asset Management LLC increased its position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 170.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,905 shares of the specialty pharmaceutical company’s stock after purchasing an additional 7,508 shares […]

Supernus Pharmaceuticals, Inc (NASDAQ:SUPN) Shares Acquired by Polar Capital Holdings Plc

Polar Capital Holdings Plc raised its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 10.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,654,470 shares of the specialty pharmaceutical company’s stock after acquiring an additional 150,000 […]

Congress Asset Management Co MA Has $25 29 Million Stock Holdings in Supernus Pharmaceuticals, Inc (NASDAQ:SUPN)

Congress Asset Management Co. MA boosted its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 19.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 917,164 shares of the specialty pharmaceutical company’s stock after buying an additional 147,105 shares during the […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.